Gland Pharma Ltd.
Snapshot View

1326.90 +16.35 ▲1.3%

31 January 2023, 09:23:57 AM
Volume: 22,548

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.glandpharma.com
Market Cap 21,573.60 Cr.
Enterprise Value(EV) 18,314.50 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 60.01 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 21.86 Trailing Twelve Months Ending 2022-12
Industry PE 32.78 Trailing Twelve Months Ending 2022-12
Book Value / Share 478.66 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.74 Calculated using Price: 1,311.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 16.47 Cr. 164,690,223 Shares
FaceValue 1
Company Profile
The company was incorporated as Gland Pharma Private Limited, a private limited company, at Hyderabad under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by the Registrar of Companies, Andhra Pradesh at Hyderabad. Subsequently, the name of the company was changed to Gland Pharma Limited pursuant to a special resolution passed by the shareholders of the Company on December 5, 1994, and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad consequent upon change of name and conversion into a public limited company under the Companies Act, 1956.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.25%
1 Week
-2.07%
1 Month
-15.84%
3 Month
-25.64%
6 Month
-41.30%
1 Year
-61.29%
2 Year
-37.30%
5 Year
10 Year
3 years 2020-03 2021-03 2022-03
Return on Equity (%) 21.29 20.97 18.61
Return on Capital Employed (%) 27.39 28.00 24.85
Return on Assets (%) 18.91 18.84 16.91

Balance Sheet View Details >>

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 3,646 5,903 7,158 7,651
Non Curr. Liab. 81 80 94 100
Curr. Liab. 359 513 582 870
Minority Int.
Equity & Liab. 4,086 6,496 7,834 8,621
Non Curr. Assets 1,240 1,372 1,982 2,312
Curr. Assets 2,846 5,124 5,852 6,309
Misc. Exp. not W/O
Total Assets 4,086 6,496 7,834 8,621

Profit Loss View Details >>

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 2,633 3,463 4,401 3,943
Other Income 139 135 224 267
Total Income 2,772 3,598 4,625 4,209
Total Expenditure -1,678 -2,161 -2,891 -2,738
PBIDT 1,095 1,437 1,734 1,471
Interest -7 -3 -5 -7
Depreciation -95 -99 -110 -140
Taxation -220 -338 -407 -336
Exceptional Items
PAT 773 997 1,212 988
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 773 997 1,212 988
Adjusted EPS 50 61 74 60

Cash Flow View Details >>

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 701 605 791
Cash Fr. Inv. -766 -1,524 -1,003
Cash Fr. Finan. -7 1,238 35
Net Change -72 319 -177
Cash & Cash Eqvt 170 492 319

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 58.36 58.25 58.14 58.02 58.00 58.00 57.87 57.86 57.86
Public 41.64 41.75 41.86 41.98 42.00 42.00 42.13 42.14 42.14
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 27 Jan 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Gland Pharma Limited has informed the Exchange about Schedule of meet
Fri, 27 Jan 2023
Updates
Gland Pharma Limited has informed the Exchange regarding 'US FDA Inspection'.
Wed, 25 Jan 2023
Copy of Newspaper Publication
Gland Pharma Limited has informed the Exchange about Copy of Newspaper Publication

Technical Scans View Details >>

Mon, 30 Jan 2023
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,040.90 -1.0%
Divi's Laboratories Ltd. 89,367.34 3,357.95 -0.2%
Cipla Ltd. 83,741.18 1,021.00 -1.3%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,347.45 +0.4%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,193.05 -1.0%
Torrent Pharmaceuticals Ltd. 52,291.51 1,550.00 +0.1%
Abbott India Ltd. 44,555.01 21,036.30 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,040.90 -1.0%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,357.95 -0.2%
Cipla Ltd. Consolidated 2022-12 31.74 1,021.00 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,347.45 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,193.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,550.00 +0.1%
Abbott India Ltd. Standalone 2022-09 50.53 21,036.30 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,040.90 -1.0%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,357.95 -0.2%
Cipla Ltd. Consolidated 2022-12 3.69 1,021.00 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,347.45 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,193.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,550.00 +0.1%
Abbott India Ltd. Standalone 2022-09 16.41 21,036.30 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.90 -1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,357.95 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,021.00 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,347.45 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,193.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,550.00 +0.1%
Abbott India Ltd. Standalone 2022-03 0.00 21,036.30 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.90 -1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,357.95 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.00 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,347.45 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,193.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,550.00 +0.1%
Abbott India Ltd. Standalone 2022-03 29.95 21,036.30 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.90 -1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,357.95 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.00 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,347.45 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,193.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,550.00 +0.1%
Abbott India Ltd. Standalone 2022-03 29.95 21,036.30 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.90 -1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,357.95 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,021.00 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,347.45 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,193.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,550.00 +0.1%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,036.30 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.90 -1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,357.95 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,021.00 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,347.45 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,193.05 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,550.00 +0.1%
Abbott India Ltd. Standalone 2022-03 798.70 21,036.30 +0.2%

FAQ's On Gland Pharma Ltd.

What is Gland Pharma share price?

Can I buy Gland Pharma shares now?

What is the Market Cap of Gland Pharma?

What are the key metrics to analyse Gland Pharma?

What is the 52 Week High and Low of Gland Pharma?

What is the trend of Gland Pharma share price?